Concourse Financial Group Securities’s Amphastar Pharmaceuticals AMPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,063
| Closed | -$38.4K | – | 321 |
|
|
2024
Q4 | $38.4K | Buy |
1,063
+104
| +11% | +$3.76K | ﹤0.01% | 1311 |
|
|
2024
Q3 | $46.5K | Buy |
959
+19
| +2% | +$922 | ﹤0.01% | 1208 |
|
|
2024
Q2 | $37.6K | Buy |
940
+48
| +5% | +$1.92K | ﹤0.01% | 1300 |
|
|
2024
Q1 | $39.2K | Buy |
892
+52
| +6% | +$2.28K | ﹤0.01% | 1291 |
|
|
2023
Q4 | $52K | Buy |
840
+69
| +9% | +$4.27K | ﹤0.01% | 1112 |
|
|
2023
Q3 | $35.5K | Sell |
771
-8
| -1% | -$368 | ﹤0.01% | 1214 |
|
|
2023
Q2 | $44.8K | Sell |
779
-50
| -6% | -$2.87K | ﹤0.01% | 1136 |
|
|
2023
Q1 | $31.1K | Sell |
829
-54
| -6% | -$2.03K | ﹤0.01% | 1287 |
|
|
2022
Q4 | $24.7K | Buy |
+883
| New | +$24.7K | ﹤0.01% | 1386 |
|
|
2022
Q3 | – | Sell |
-747
| Closed | -$26K | – | 2235 |
|
|
2022
Q2 | $26K | Sell |
747
-422
| -36% | -$14.7K | ﹤0.01% | 1347 |
|
|
2022
Q1 | $42K | Buy |
1,169
+323
| +38% | +$11.6K | ﹤0.01% | 1199 |
|
|
2021
Q4 | $20K | Buy |
846
+217
| +34% | +$5.13K | ﹤0.01% | 1621 |
|
|
2021
Q3 | $12K | Buy |
629
+128
| +26% | +$2.44K | ﹤0.01% | 1812 |
|
|
2021
Q2 | $10K | Buy |
+501
| New | +$10K | ﹤0.01% | 1857 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 2475 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 2424 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2291 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2203 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2286 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2199 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1892 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2337 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2365 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2230 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1763 |
|